Verona Pharma PLC (VRNA)
35.37
-1.56
(-4.22%)
USD |
NASDAQ |
Nov 14, 16:00
35.50
+0.13
(+0.37%)
After-Hours: 06:53
Verona Pharma Cash and Short Term Investments (Quarterly): 336.04M for Sept. 30, 2024
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2024 | 336.04M |
| June 30, 2024 | 404.60M |
| March 31, 2024 | 254.88M |
| December 31, 2023 | 271.77M |
| September 30, 2023 | 257.37M |
| June 30, 2023 | 270.73M |
| March 31, 2023 | 291.42M |
| December 31, 2022 | 227.83M |
| September 30, 2022 | 231.70M |
| June 30, 2022 | 111.51M |
| March 31, 2022 | 132.76M |
| December 31, 2021 | 148.38M |
| September 30, 2021 | 166.55M |
| June 30, 2021 | 146.04M |
| March 31, 2021 | 169.60M |
| December 31, 2020 | 187.99M |
| September 30, 2020 | 201.97M |
| June 30, 2020 | 22.26M |
| March 31, 2020 | 25.68M |
| December 31, 2019 | 40.81M |
| September 30, 2019 | 50.48M |
| June 30, 2019 | 58.96M |
| March 31, 2019 | 70.48M |
| December 31, 2018 | 82.10M |
| September 30, 2018 | 89.76M |
| Date | Value |
|---|---|
| June 30, 2018 | 90.02M |
| March 31, 2018 | 101.77M |
| December 31, 2017 | 108.47M |
| September 30, 2017 | 114.49M |
| June 30, 2017 | 123.04M |
| December 31, 2016 | 49.09M |
| June 30, 2016 | 1.609M |
| June 30, 2016 | 1.609M |
| December 31, 2015 | 5.221M |
| June 30, 2015 | 9.583M |
| June 30, 2015 | 9.583M |
| December 31, 2014 | 15.52M |
| June 30, 2014 | 20.61M |
| June 30, 2014 | 20.61M |
| December 31, 2013 | 0.9956M |
| June 30, 2013 | 1.415M |
| June 30, 2013 | 1.415M |
| December 31, 2012 | 1.553M |
| June 30, 2012 | 3.701M |
| June 30, 2012 | 3.701M |
| December 31, 2011 | 3.922M |
| June 30, 2011 | 1.848M |
| December 31, 2010 | 3.091M |
| June 30, 2010 | 4.376M |
| December 31, 2009 | 4.576M |
Cash and Short Term Investments Definition
Cash and Short Term investments is the sum of two balance sheet line items: cash and equivalents and short term investments in marketable securities.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
22.26M
Minimum
Jun 2020
404.60M
Maximum
Jun 2024
194.99M
Average
194.98M
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Adaptimmune Therapeutics PLC | 214.79M |
| Biodexa Pharmaceuticals PLC | 6.394M |
| NuCana PLC | 14.72M |
| TC BioPharm (Holdings) PLC | 1.238M |
| Autolus Therapeutics PLC | 705.94M |